Issue No. 8
Stem Cell Treatment Not Ready for Prime TimeDate: April 23, 2010
If you’ve seen the ads for stem cell treatments offered abroad for conditions ranging from Alzheimer’s disease to stroke, you’re not alone.
Neurologist Nicholas Maragakis, M.D., says not to get caught up in the claims. “This kind of advertised stem cell therapy just isn’t ready for prime time,” he explains.
Nearly all the ads are based on patient testimonials, not published results, Maragakis adds. Plus, they lack sound scientific explanations for how or why they should be working.
But Maragakis and his Johns Hopkins colleagues are making progress in stem cell therapy research for neurological conditions and brain cancer.
“Stem cell research is promising and exciting,” says neurosurgeon Alfredo Quiñones-Hinojosa, M.D., “but that’s not to say it’s anywhere near ready for clinical use.”
Uncover the truth. Learn more about stem cell therapy research taking place at Johns Hopkins. Visit hopkinsmedicine.org/stem_cell_research.